Evidence map›Paper›PMID 34348671›Full record

SynthesisBMC infectious diseases2021

Prevalence of strongyloidiasis in Peru: systematic review and meta-analysis.

Sonia Ortiz-Martínez, José-Manuel Ramos-Rincón, María-Esteyner Vásquez-Chasnamote, Olga-Nohelia Gamboa-Paredes, Katty-Madeleine Arista-Flores, Luis-Alfredo Espinoza-Venegas, Eva de-Miguel-Balsa, Viviana-Vanessa Pinedo-Cancino, Miguel Górgolas-Hernández-Mora, Martín Casapía-Morales

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Evaluation of Each ThreeMicroorganisms · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sonia Ortiz-Martínez *Medical Practice El Ballestero, Health Service of Castilla La Mancha, Albacete, Spain.
José-Manuel Ramos-Rincón *Clinical Medicine Department, University Miguel Hernández of Elche, Ctra N-332, 03550 Sant Joan d'Alacant, Alicante, Spain. jramosrincon@yahoo.es.ORCID http://orcid.org/0000-0002-6501-9867
María-Esteyner Vásquez-ChasnamoteNatural Resources Research Center. National University of the Peruvian Amazon, Iquitos, Peru.
Olga-Nohelia Gamboa-ParedesResearch Assistant. Amazon Rainforest Civil Association, Iquitos, Peru.
Katty-Madeleine Arista-FloresResearch Assistant. Amazon Rainforest Civil Association, Iquitos, Peru.
Luis-Alfredo Espinoza-VenegasInfectious Diseases and Tropical Medicine Service, Loreto Regional Hospital, Iquitos, Peru.
Eva de-Miguel-BalsaClinical Medicine Department, University Miguel Hernández of Elche, Ctra N-332, 03550 Sant Joan d'Alacant, Alicante, Spain.
Viviana-Vanessa Pinedo-CancinoMolecular Biology and Immunology Laboratory of the Specialized Unit of LIPNAA-CIRNA, National University of the Peruvian Amazon, Iquitos, Peru.
Miguel Górgolas-Hernández-Mora *Infectious Disease Division, University Hospital Foundation Jiménez Díaz, Madrid, Spain.
Martín Casapía-Morales *Infectious Diseases and Tropical Medicine Service, Loreto Regional Hospital, Iquitos, Peru.

Funding

University Development Cooperation Program, Miguel Hernández University of Elche and Generalitat Valenciana. SOLCIF/2017/0005
6 · The paper itself

Abstract

backgroundStrongyloidiasis is a disease of great public health significance, caused by the parasitic nematodes Strongyloides stercoralis, Strongyloides fuelleborni, and Strongyloides fuelleborni subsp. kellyi. This systematic review and meta-analysis aimed to assess the prevalence of Strongyloides stercoralis infection in Peru.

methodsThe review was based on a literature search in PubMed, SciELO and Google Scholar using the key words or root words "strongyl*" AND "Peru" on 15 July 2020. Eligible studies were published from 1 January 1981 to 15 July 2020 and written in English, Spanish, Italian, or French.

resultsWe included 21 papers in the analysis. Studies were heterogeneous in terms of study population and diagnostic methods (e.g. Baermann technique, agar, Dancescu or charcoal cultures, serology, string capsule). Prevalence of S. stercoralis ranged from 0.3 to 45%. The pooled proportion of Strongyloides in the general population was 7.34% (95% CI 4.97 to 10.13%). Half the studies were designed to detect parasites in general. In studies designed to detect S. stercoralis, the most widely used diagnostic method was the Baermann technique.

conclusionPrevalence of S. stercoralis in Peru was high but varied by geographic area, techniques for stool examination, and participant characteristics.

Indexed as

Strongyloides stercoralisStrongyloidiasisAnimalsFecesHumansPeruPrevalencePeruPrevalenceSerologySeroprevalenceStrongyloides stercoralis

Identifiers

PMID34348671
PMCPMC8336367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.